Patent details

Basic Information

Publication number:

EP3095795

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP161776562

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS

French Title of Invention:

ANTICORPS ANTI-C5 PRÉSENTANT UNE PHARMACOCINÉTIQUE AMÉLIORÉE

German Title of Invention:

ANTI-C5 ANTIKÖRPER MIT VERBESSERTER PHARMAKOKINETIC

SPC Number:

Dates

Filing date:

06/03/2015

Grant date:

10/07/2019

EP Publication Date:

23/11/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/07/2019

EP B1 Publication Date:

10/07/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

06/03/2020

Expiration date:

06/03/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/07/2019

 

 

Name:

Alexion Pharmaceuticals, Inc.

Address:

121 Seaport Boulevard, Boston, MA 02210, United States (US)

Inventor

1

Name:

WANG, Yi

Address:

United States (US)

2

Name:

TAMBURINI, Paul P

Address:

United States (US)

3

Name:

ANDRIEN, Bruce, A., Jr.

Address:

United States (US)

4

Name:

SHERIDAN, Douglas L

Address:

United States (US)

Priority

Priority Number:

201461949932 P

Priority Date:

07/03/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61P 29/00; A61P 37/06; C07K 16/18; C07K 16/40;

Publication

European Patent Bulletin

Issue number:

201928

Publication date:

10/07/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages